We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » OTC Maker Gets Warning Letter for GMP Violations, Unapproved Drug
OTC Maker Gets Warning Letter for GMP Violations, Unapproved Drug
Trinidad-based OTC drug manufacturer CGA drew a warning letter from the FDA for serious GMP lapses including inadequate testing and producing an unapproved drug.